Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Abate

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Oxidative Medicine and Cellular Longevity|May 5, 2018
Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 PathwayW Rungratanawanich, G Abate, M M Serafini, et al.
Tumori|February 28, 1983
Influence on response to therapy and overall survival of mediastinal involvement by Hodgkin's diseaseP Comella, V De Rosa, P Frezza, et al.
European Journal of Haematology|January 1, 1995
Three-year results of MIM salvage treatment for refractory/relapsed intermediate grade NHLG Abate, S Tafuto, G Marcacci, et al.
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1978
[Exercise tests with the bicycle ergometer in normal subjects: evaluation of changes in heart rate, systolic arterial pressure and the double product during exercise]F Zacà, P C Pavesi, P L Pagliarani, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2021
Evaluation of Factors Associated With Fracture and Loss of Bone Mineral Density Within 1 Year After Liver TransplantationEjigayehu G Abate, Myrian Vinan Vega, Ana M Rivas, et al.
Current Pharmaceutical Design|August 22, 2006
Frailty of older age: the role of the endocrine--immune interactionR Paganelli, A Di Iorio, A Cherubini, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term resultsP Comella, G Abate, M Fiore, et al.
Tumori|February 28, 1987
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomasG Abate, P Comella, N Di Pietro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapyS Tafuto, G Abate, P D'Andrea, et al.
Minerva Medica|March 1, 1991
[Controlled multicenter study on the therapeutic effectiveness of mesoglycan in patients with cerebrovascular disease]G Abate, A Berenga, F Caione, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Oxidative Medicine and Cellular Longevity|May 5, 2018
Characterization of the Antioxidant Effects of <i>γ</i>-Oryzanol: Involvement of the Nrf2 PathwayW Rungratanawanich, G Abate, M M Serafini, et al.
Tumori|February 28, 1983
Influence on response to therapy and overall survival of mediastinal involvement by Hodgkin's diseaseP Comella, V De Rosa, P Frezza, et al.
European Journal of Haematology|January 1, 1995
Three-year results of MIM salvage treatment for refractory/relapsed intermediate grade NHLG Abate, S Tafuto, G Marcacci, et al.
Bollettino Della Societa Italiana Di Cardiologia|January 1, 1978
[Exercise tests with the bicycle ergometer in normal subjects: evaluation of changes in heart rate, systolic arterial pressure and the double product during exercise]F Zacà, P C Pavesi, P L Pagliarani, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2021
Evaluation of Factors Associated With Fracture and Loss of Bone Mineral Density Within 1 Year After Liver TransplantationEjigayehu G Abate, Myrian Vinan Vega, Ana M Rivas, et al.
Current Pharmaceutical Design|August 22, 2006
Frailty of older age: the role of the endocrine--immune interactionR Paganelli, A Di Iorio, A Cherubini, et al.
Journal of Chemotherapy (Florence, Italy)|July 1, 1989
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term resultsP Comella, G Abate, M Fiore, et al.
Tumori|February 28, 1987
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomasG Abate, P Comella, N Di Pietro, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapyS Tafuto, G Abate, P D'Andrea, et al.
Minerva Medica|March 1, 1991
[Controlled multicenter study on the therapeutic effectiveness of mesoglycan in patients with cerebrovascular disease]G Abate, A Berenga, F Caione, et al.
Pageof 18